Critical Reviews in Oncology/Hematology

eISSN: 1879-0461pISSN: 1040-8428

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
9.7
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.75
4
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    ELSEVIER SCIENCE INC
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 22%
4-6 53%
7-9 17%
>9 8%

Topics Covered

Cancer
Lung cancer
Reactive oxygen species
Antigen
Cisplatin
Immunotherapy
Breast cancer
Glucocorticoid
Immune checkpoint inhibitors
Hepatocellular carcinoma
Quality of life
Chemoradiotherapy
Carcinogenesis
Overall survival
Confidence interval
Epidermal growth factor receptor
Toxicity
Ovarian cancer
Meta-analysis
Oxidative stress

Recently Published Papers

Year-wise Publication

FAQs

Since when has Critical Reviews in Oncology/Hematology been publishing? Faqs

The Critical Reviews in Oncology/Hematology has been publishing since 1989 till date.

How frequently is the Critical Reviews in Oncology/Hematology published? Faqs

Critical Reviews in Oncology/Hematology is published Monthly.

Who is the publisher of Critical Reviews in Oncology/Hematology? Faqs

The publisher of Critical Reviews in Oncology/Hematology is ELSEVIER SCIENCE INC.

How can I view the journal metrics of Critical Reviews in Oncology/Hematology on editage? Faqs

For the Critical Reviews in Oncology/Hematology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Critical Reviews in Oncology/Hematology? Faqs

The eISSN number is 1879-0461 and pISSN number is 1040-8428 for Critical Reviews in Oncology/Hematology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Lung cancer, Reactive oxygen species, Antigen, Cisplatin, Immunotherapy, Breast cancer, Glucocorticoid, Immune checkpoint inhibitors, Hepatocellular carcinoma, Quality of life, Chemoradiotherapy, Carcinogenesis, Overall survival, Confidence interval, Epidermal growth factor receptor, Toxicity, Ovarian cancer, Meta-analysis, Oxidative stress.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.